Effect Study of Parecoxib to Treat Emergence Delirium and Postoperative Pain

PHASE4UnknownINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

June 30, 2012

Conditions
Emergence DeliriumPostoperative Pain
Interventions
DRUG

Parecoxib

The study group will receive first dose of intravenous (IV) injection of parecoxib sodium 40 mg (in a volume of 2 ml) 60 min before the anticipated end of surgery, followed 2 ml IV injection of parecoxib 40 mg will be occurred at 12, 24 and 36 h after the first dose of parecoxib.

Trial Locations (1)

510080

RECRUITING

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER